Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human leukemia cell lines

Leukemia Research

Volumn 26, Issue 10, 2002, Pages 927-931

  Richard, Doriane ^a   Morjani, Hamid ^a   Chénais, Benoı̂t ^a  

^a CNRS   (France)

Author keywords

Aclarubicin; Differentiation; HL 60; K562; Labile iron pool; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ACLARUBICIN; CALCEIN; DEFEROXAMINE; ETHIDIUM; FLUORESCENT DYE; FREE RADICAL; IRON; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HOMEOSTASIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROFLUOROMETRY; TUMOR DIFFERENTIATION;

ACLARUBICIN; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIFFERENTIATION; FLUORESCENT DYES; FREE RADICALS; HL-60 CELLS; HUMANS; IRON; K562 CELLS; LEUKEMIA; REACTIVE OXYGEN SPECIES;

EID: 0036342473     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00030-9     Document Type: Article

References (39)

1. Anthracyclines in the treatment of cancer. An overview
2. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
3. Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue
4. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase
5. Free radical formation by antitumor quinones
6. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
7. Anthracyclines as inducers of tumor cell differentiation
8. Anthracyclines as tumor cell differentiating agents: Effects on the regulation of erythroid gene expression
9. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukaemia cells by anthracyclines
10. Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells
11. Anthracycline-induced oxidative stress: Its role in the development of cardiac damage
12. Adriamycin cardiomyopathy: Pathophysiology and prevention
13. Oxidative stress involvement in chemically induced differentiation of K562 cells
14. Biologically relevant metal ion-dependent hydroxyl radical generation, an update
15. Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction
16. Role of iron in anthracycline cardiotoxicity: New tunes for an old song
17. Fluorescence analysis of the labile iron pool of mammalian cells
18. Molecular control of vertebrate iron metabolism: MRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress
19. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells
20. Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution
21. Enzymatic activation and binding of adriamycin to nuclear DNA
22. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals
23. The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart
24. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice
25. Induction of granulocytic maturation of HL-60 human leukemia cells by free radicals: A hypothesis of cell differentiation involving hydroxyl radicals
26. Involvement of Fenton reaction products in differentiation induction of K562 human leukemia cells
27. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate
28. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells
29. Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen
30. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium
31. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy
32. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells
33. Enhancement of radiation-induced cell killing and DNA double-strand breaks in a human tumor cell line using nanomolar concentrations of aclacinomycin A
34. Decreased repair of radiation-induced DNA double-strand breaks with cellular differentiation
35. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase
36. Iron deprivation-induced apoptosis in HL-60 cells
37. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells
38. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells
39. Effects of hemin on apoptosis, suppression of cytochrome c oxidase gene expression, and bone-marrow toxicity induced by doxorubicin (adriamycin)